Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. 4basebio Plc Share Price
  4. 4basebio Plc Share Regulatory News

Pin to quick picks4basebio Plc Regulatory News (4BB)

4basebio Plc Information

Share Price Information for 4basebio Plc (4BB)

Share Price is delayed by 15 minutes
Get Live Data
547.50    -2.50 (-0.45%)
Bid:
520.00
Ask:
575.00
Spread: 55.00 (10.577%)
Market Cap: £84.78m
4BB Live PriceLast checked at - London Stock Exchange

Intraday 4basebio Plc Share Chart

123
Date   Source Headline
3rd Oct 20241:25 pmPRNHolding(s) in Company
3rd Oct 20241:25 pmPRNHolding(s) in Company
27th Sep 20247:00 amPRNHalf-year Report
9th Sep 20247:00 amPRNUpdate re Equity Issuance, Secondary Sale and the board
8th Aug 20243:37 pmPRNStrategic Advisory Board & Appointment of Director
29th Jul 20244:31 pmPRN£40.0m Equity Issuance and £29.4m Secondary Sale
18th Jul 20247:00 amPRNEmployee Long Term Incentive Plan and Issue of Equity
28th Jun 20243:45 pmPRNResult of AGM
11th Jun 20242:42 pmPRNHolding(s) in Company
11th Jun 20247:00 amPRNHolding(s) in Company
11th Jun 20247:00 amPRNHolding(s) in Company
11th Jun 20247:00 amPRNHolding(s) in Company
5th Jun 20247:00 amPRNFinal Results and Notice of AGM
30th May 20243:30 pmPRNHolding(s) in Company
10th Apr 20247:00 amPRN4basebio announces the supply of its opDNA™ DNA products into Tier 1 Pharma client's vaccine program
21st Mar 20247:00 amPRN4basebio client's Phase I clinical trials for opDNA™ based mRNA vaccine
1st Mar 20247:00 amPRN4basebio awarded tender to deliver research and GMP-grade synthetic DNA in CPI's tender process for supplying its RNA Centre of Excellence
6th Feb 20247:01 amPRNHolding(s) in Company
6th Feb 20247:01 amPRNHolding(s) in Company
6th Feb 20247:01 amPRNHolding(s) in Company
6th Feb 20247:01 amPRNHolding(s) in Company
6th Feb 20247:00 amPRNExercise of Options
5th Feb 20247:01 amPRNHolding(s) in Company
5th Feb 20247:01 amPRNHolding(s) in Company
5th Feb 20247:01 amPRNHolding(s) in Company
5th Feb 20247:00 amPRNDirectors' Dealings
2nd Feb 20247:00 amPRNLong-Term Incentive Plan and Exercise of Options
21st Sep 20237:00 amPRNHalf-year Report
1st Aug 20237:00 amPRNGrant received from the Bill and Melinda Gates Foundation
27th Sep 20229:05 amRNSSecond Price Monitoring Extn
27th Sep 20229:00 amRNSPrice Monitoring Extension
6th May 20222:00 pmRNSPrice Monitoring Extension
23rd Mar 20227:00 amPRNRapidly Produced Customisable Synthetic DNA
15th Mar 20224:41 pmRNSSecond Price Monitoring Extn
15th Mar 20224:35 pmRNSPrice Monitoring Extension
15th Mar 20222:05 pmRNSSecond Price Monitoring Extn
15th Mar 20222:01 pmRNSPrice Monitoring Extension
15th Mar 202211:00 amRNSPrice Monitoring Extension
15th Mar 20229:00 amRNSPrice Monitoring Extension
8th Mar 20229:00 amRNSPrice Monitoring Extension
15th Feb 20227:00 amPRNDNA manufacturing update
18th Jan 20227:00 amPRNStrategic Research Collaboration
20th Dec 202112:49 pmPRNDirector/PDMR Shareholding
13th Dec 20213:55 pmPRNDirector/PDMR Shareholding
23rd Nov 20217:00 amPRNJoint Development Agreement with Leucid Bio
30th Sep 20217:00 amPRNHalf-year Report
28th Sep 20217:00 amPRNDevelopment of GMP Manufacturing Capacity
4th Aug 20214:40 pmRNSSecond Price Monitoring Extn
4th Aug 20214:35 pmRNSPrice Monitoring Extension
23rd Jul 20213:39 pmPRNFurther re Conversion to UK PLC
123

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
JAGI
Jp Morg.as
LSE
0.32%
DSG
Dillistone
LSE
0.00%
ORCA
Orcadian Engy
LSE
0.00%
JGC
Jupiter Gr.
LSE
0.00%
GSS
GSS.L
LSE
0.00%
Trending
BSFA
Bio-Sustainable Future Enterprises
LSE
-20.00%
QHE
Quantum Helium
LSE
-6.54%
CPI
Capita
LSE
-8.23%
GGP
Greatland Resources
LSE
0.07%
LLOY
Lloyds
LSE
-1.20%